Connect with us

National

New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

Published

on

Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …

Click here to view the original article.